NCT05612711View on ClinicalTrials.gov

Dronabinol for Agitation in Dementia Crossover Trial

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

November 30, 2023

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2026

Conditions
Dementia ModerateDementia SevereAgitation,PsychomotorBehavioral Symptoms
Interventions
DRUG

Dronabinol

All participants will take both dronabinol and placebo at different points in the study in this crossover design trial.

Trial Locations (1)

29401

Ralph H. Johnson VA Health Care System, Charleston

Sponsors
All Listed Sponsors
collaborator

JHSPH Center for Clinical Trials

OTHER

lead

Ralph H. Johnson VA Medical Center

FED